Drug recall · March 1, 2017
Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules recall
Why: Superpotent Drug and Subpotent Drug; potency failures obtained
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX
- Lots / codes
2016-08-22:37@28, exp 2/18/2017
- Quantity
- 90 capsules
- Company
- Moore's Compounding Pharmacy, Corpus Christi, TX
- Distribution
- TX
- Initiated
- September 12, 2016 · Voluntary: Firm initiated
- Classified
- February 21, 2017
- Reported
- March 1, 2017
- Ended
- May 17, 2017
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levothyroxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.